REYON Pharmaceutical Co., Ltd. (KRX: 102460)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,820
-490 (-3.68%)
Dec 19, 2024, 9:00 AM KST

REYON Pharmaceutical Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
615.83,5837,4345,5373,8444,946
Upgrade
Depreciation & Amortization
4,1204,7824,5344,6664,5654,088
Upgrade
Loss (Gain) From Sale of Assets
39.08-1.68-24.41140.92-19.92-184.88
Upgrade
Loss (Gain) From Sale of Investments
2,6612,453-4,262-1,125-1,573-97.92
Upgrade
Loss (Gain) on Equity Investments
1,478960.181,968-1,684475.29548.55
Upgrade
Provision & Write-off of Bad Debts
17.98-63.38-79.34467.28-1,243-484.34
Upgrade
Other Operating Activities
133.77-439.2-1,7491,895-409.92-23,621
Upgrade
Change in Accounts Receivable
1,2751,947-1,134-986.614,5863,579
Upgrade
Change in Inventory
-5,516-5,067-3,6772,005-4,431-3,208
Upgrade
Change in Accounts Payable
511.923,39461.52563.6149.39433.7
Upgrade
Change in Income Taxes
-342.94-342.94----
Upgrade
Change in Other Net Operating Assets
-484.23-1,7814,460199.4-1,4752,240
Upgrade
Operating Cash Flow
3,7328,6458,72911,6854,599-12,184
Upgrade
Operating Cash Flow Growth
-71.23%-0.96%-25.29%154.04%--
Upgrade
Capital Expenditures
-23,345-28,870-63,133-116,978-52,308-50,930
Upgrade
Sale of Property, Plant & Equipment
-1.7242.2784.37247.69
Upgrade
Divestitures
-----190.04
Upgrade
Sale (Purchase) of Intangibles
488.93-2.5--18.7421.46-450.91
Upgrade
Investment in Securities
-1,08119,97910,5662,07622,22283,986
Upgrade
Other Investing Activities
167.64152.12-38.93231.165.5-145.7
Upgrade
Investing Cash Flow
-23,769-8,739-52,564-114,682-29,59432,898
Upgrade
Short-Term Debt Issued
---3,5007,00012,000
Upgrade
Long-Term Debt Issued
-13,100113,900150,10032,900900
Upgrade
Total Debt Issued
4,78013,100113,900153,60039,90012,900
Upgrade
Long-Term Debt Repaid
--2,205-116,104-2,475-2,678-28,255
Upgrade
Total Debt Repaid
-5,627-2,205-116,104-2,475-2,678-28,255
Upgrade
Net Debt Issued (Repaid)
-847.2410,895-2,204151,12537,222-15,355
Upgrade
Issuance of Common Stock
---10,000--
Upgrade
Repurchase of Common Stock
----76.31--
Upgrade
Dividends Paid
-2,751-2,738-4,563-3,464-5,785-8,264
Upgrade
Other Financing Activities
-0-3.83--9.23-45.27-49.6
Upgrade
Financing Cash Flow
-3,5988,153-6,767157,57631,392-23,668
Upgrade
Foreign Exchange Rate Adjustments
-11.11-1.28-89.04-34-26.17-0.38
Upgrade
Miscellaneous Cash Flow Adjustments
--0-0-0--
Upgrade
Net Cash Flow
-23,6478,058-50,69154,5446,371-2,954
Upgrade
Free Cash Flow
-19,613-20,225-54,404-105,293-47,708-63,113
Upgrade
Free Cash Flow Margin
-13.09%-13.39%-35.32%-73.73%-36.69%-47.97%
Upgrade
Free Cash Flow Per Share
-1069.34-1102.71-2979.96-5942.30-2801.53-3743.71
Upgrade
Cash Interest Paid
184.54195.52124.0293.37479.4366.25
Upgrade
Cash Income Tax Paid
813.59950.651,188-1,488620.5825,277
Upgrade
Levered Free Cash Flow
51,979-25,600-61,372-109,157-40,494-64,940
Upgrade
Unlevered Free Cash Flow
52,094-25,477-61,296-109,087-40,383-64,867
Upgrade
Change in Net Working Capital
-68,3002,4955,476-2,278-5,90521,714
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.